Literature DB >> 14576134

In vitro analysis of the ability of Trichophyton rubrum to become resistant to terbinafine.

Colin S Osborne1, Bettina Hofbauer, Bertrand Favre, Neil S Ryder.   

Abstract

In this study, we have investigated in vitro the resistance frequency and development of resistance to terbinafine of Trichophyton rubrum. Results demonstrated that naturally occurring mutants are rare and that T. rubrum appears to have little capacity to develop resistance to terbinafine even after prolonged exposure.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14576134      PMCID： PMC253782          DOI： 10.1128/AAC.47.11.3634-3636.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using a microdilution assay.

Authors:  Bertrand Favre; Bettina Hofbauer; Kwang-Soo Hildering; Neil S Ryder
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

2.  Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

Authors:  Pranab K Mukherjee; Steven D Leidich; Nancy Isham; Ingrid Leitner; Neil S Ryder; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  Cross-Resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis.

Authors:  E W Cross; S Park; D S Perlin
Journal:  Microb Drug Resist       Date:  2000       Impact factor: 3.431

4.  Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.

Authors:  D Sanglard; F Ischer; J Bille
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

5.  Office practice-based confirmation of onychomycosis: a US nationwide prospective survey.

Authors:  Boni E Elewski; James Leyden; Michael G Rinaldi; Ercem Atillasoy
Journal:  Arch Intern Med       Date:  2002-10-14

6.  Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent.

Authors:  E K Manavathu; J A Vazquez; P H Chandrasekar
Journal:  Int J Antimicrob Agents       Date:  1999-08       Impact factor: 5.283

Review 7.  New developments in chemotherapy for non-invasive fungal infections.

Authors:  M A Hossain; M A Ghannoum
Journal:  Expert Opin Investig Drugs       Date:  2001-08       Impact factor: 6.206

Review 8.  Cutaneous infections dermatophytosis, onychomycosis, and tinea versicolor.

Authors:  Melody R Vander Straten; Mohammad A Hossain; Mahmoud A Ghannoum
Journal:  Infect Dis Clin North Am       Date:  2003-03       Impact factor: 5.982

9.  In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin.

Authors:  B Hofbauer; I Leitner; N S Ryder
Journal:  Med Mycol       Date:  2002-04       Impact factor: 4.076

10.  Survey of dermatophyte infections in the Lausanne area Switzerland.

Authors:  Michael Monod; Sandra Jaccoud; Christophe Zaugg; Barbara Léchenne; Florence Baudraz; Renato Panizzon
Journal:  Dermatology       Date:  2002       Impact factor: 5.366
View more
  12 in total

1.  Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes.

Authors:  M A Ghannoum; V Chaturvedi; A Espinel-Ingroff; M A Pfaller; M G Rinaldi; W Lee-Yang; D W Warnock
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

2.  Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafine.

Authors:  Colin S Osborne; Ingrid Leitner; Bettina Hofbauer; Ceri A Fielding; Bertrand Favre; Neil S Ryder
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis.

Authors:  Mayur M Patel; Zeal M Vora
Journal:  Drug Deliv Transl Res       Date:  2016-06       Impact factor: 4.617

4.  In vitro and in vivo assessment of dermatophyte acquired resistance to efinaconazole, a novel triazole antifungal.

Authors:  Atsushi Iwata; Yoko Watanabe; Naomichi Kumagai; Maria Katafuchi-Nagashima; Keita Sugiura; Radhakrishnan Pillai; Yoshiyuki Tatsumi
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

5.  Potential of Ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum.

Authors:  Emilia Ghelardi; Francesco Celandroni; Sokhna Aissatou Gueye; Sara Salvetti; Sonia Senesi; Anna Bulgheroni; Federico Mailland
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

6.  Amino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafine.

Authors:  Colin S Osborne; Ingrid Leitner; Bertrand Favre; Neil S Ryder
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Terbinafine Resistance of Trichophyton Clinical Isolates Caused by Specific Point Mutations in the Squalene Epoxidase Gene.

Authors:  Tsuyoshi Yamada; Mari Maeda; Mohamed Mahdi Alshahni; Reiko Tanaka; Takashi Yaguchi; Olympia Bontems; Karine Salamin; Marina Fratti; Michel Monod
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

8.  Increase in resistance to fluconazole and itraconazole in Trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure.

Authors:  Anita Hryncewicz-Gwóźdź; Katarzyna Kalinowska; Ewa Plomer-Niezgoda; Jacek Bielecki; Tomasz Jagielski
Journal:  Mycopathologia       Date:  2013-04-18       Impact factor: 2.574

9.  Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus.

Authors:  Wei Liu; Gregory S May; Michail S Lionakis; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

10.  Molecular Epidemiology and Antifungal Susceptibility of Trichophyton Isolates in Greece: Emergence of Terbinafine-Resistant Trichophytonmentagrophytes Type VIII Locally and Globally.

Authors:  Maria Siopi; Ioanna Efstathiou; Konstantinos Theodoropoulos; Spyros Pournaras; Joseph Meletiadis
Journal:  J Fungi (Basel)       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.